Delivery Order SPE2DR25D3301-SPE2DR26F20GS
- Not listed
- The Defense Logistics Agency awarded a $2,380.48 delivery order to AmerisourceBergen Drug Corp for LUMASON 25 mg vials, with an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime contractor on this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,066.02 for Lumason 25 mg vials, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, aligning with the vendor's corporate headquarters location. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,734.54 to AmerisourceBergen Drug Corp for the supply of Lumason 25 mg vials, with an ultimate completion date of December 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a Delivery Order valued at $2,388.88 to AmerisourceBergen Drug Corp for the supply of Lumason 25 mg vials, with an ultimate completion date of August 25, 2025. This firm fixed-price contract was competitively awarded without set-aside designations and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,949.88 on December 31, 2025, for the supply of LUMASON 25 mg vials, with completion scheduled for January 2, 2026. This is a firm fixed price contract with no set-aside designation, executed through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,194.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumason 25 mg vials, a contrast agent used in ultrasound imaging procedures. The contract, awarded on May 8, 2025, with an ultimate completion date of May 9, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This award was not designated as a set-aside contract and was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Lumason 25 mg vials, a diagnostic imaging agent used in ultrasound procedures. This firm fixed-price delivery order, valued at $1,445.45, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999 ceiling and extends through December 2026. The order was...
- This federal contract award is a delivery order valued at $5,546.58 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LUMASON 25 MG VIALS, a medical product, and has a firm fixed price. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $593 to Amerisourcebergen Drug Corporation to supply LUMASON 25 MG VIALS. As the prime contractor, Amerisourcebergen will deliver the ultrasound contrast agent to its Conshohocken, Pennsylvania location by September 1, 2023 under the terms of the order. The Defense Logistics Agency functions to support America's armed forces by procuring their supplies and equipment, so this contract likely provides...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,304.62 by the Defense Logistics Agency (DLA) on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract involves the delivery of Lumason 25 mg vials and is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement action under DLA's broader...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20GSDelivery Order
The Defense Logistics Agency awarded a $1,740.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumason 25 mg vials, with an ultimate completion date of January 7, 2026. This non-set-aside contract was competitively awarded on January 6, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in supplying critical medical products to federal healthcare systems, particularly those supporting military personnel and veterans. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Lumason (sulfur hexafluoride microbubbles) is an ultrasound contrast agent used in diagnostic imaging applications within military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/5/26 |